RU 58841-Myristate Prodrug Development for Topical Treatment of Acne and Androgenetic Alopecia
January 2005
in “
PubMed
”
TLDR RUM-loaded SLN shows promise for treating acne and hair loss topically.
The study focused on developing RU 58841-myristate (RUM) as a prodrug for topical treatment of acne and androgenetic alopecia. RUM, which has minimal affinity for the androgen receptor, was rapidly converted to the potent antiandrogen RU 58841 by various human skin cells. To enhance targeting to hair follicles, RUM was loaded onto solid lipid nanoparticles (SLN). These SLN were physically stable and showed negligible permeation through reconstructed epidermis and porcine skin, suggesting a localized effect. Fluorescence and transmission electron microscopy confirmed the targeting of SLN to hair follicles. The findings supported the potential of RUM-loaded SLN for topical antiandrogen therapy.
